UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray

Pediatrics (Evanston), 2000-02, Vol.105 (2), p.E22-e22

2000

Volltextzugriff (PDF)

Comparison of once-daily to twice-daily treatment with mometasone furoate dry powder inhaler

Annals of allergy, asthma, & immunology, 2001, Vol.86 (1), p.36-43

2001

Volltextzugriff (PDF)

Vemurafenlb Improves Overall Survival Compared to Dacarbazlne In Advanced BRAFV600E-mutated Melanoma: Updated Survival Results From a Phase III Randomised, Open-label, Multlcentre Trial

European journal of cancer (1990), 2011, Vol.47, p.14-14

2011

Volltextzugriff (PDF)

Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler

Respiratory medicine, 1999-09, Vol.93 (9), p.603-612

1999

Volltextzugriff (PDF)

Comparison of the efficacy and safety of mometasone furoate dry powder inhaler to budesonide Turbuhaler

The European respiratory journal, 2000-11, Vol.16 (5), p.808-816

2000

Volltextzugriff (PDF)

The Responsiveness of Disease-Specific and Generic Health Measures to Changes in the Severity of Asthma among Adults

Quality of life research, 1998-04, Vol.7 (3), p.235-244

1998

Volltextzugriff (PDF)

Onset of action of mometasone furoate nasal spray (NASONEX®) in seasonal allergic rhinitis

Allergy (Copenhagen), 1999-01, Vol.54 (1), p.64-69

1999

Volltextzugriff (PDF)

Pharmacodynamic activity demonstrated in phase I for PLX3397, a selective inhibitor of FMS and Kit

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.3093-3093

2011

Volltextzugriff (PDF)

Once-daily mometasone furoate dry powder inhaler in the treatment of patients with persistent asthma

Annals of allergy, asthma, & immunology, 2000-04, Vol.84 (4), p.417-424

2000

Volltextzugriff (PDF)

Assessment by nasal biopsy of long-term use of mometasone furoate aqueous nasal spray (Nasonex) in the treatment of perennial rhinitis

Otolaryngology-head and neck surgery, 1998-05, Vol.118 (5), p.648-654

1998

Volltextzugriff (PDF)

A dose-ranging study of mometasone furoate aqueous nasal spray in children with seasonal allergic rhinitis

Journal of allergy and clinical immunology, 1999-07, Vol.104 (1), p.107-114

1999

Volltextzugriff (PDF)

Once‐daily mometasone furoate aqueous nasal spray (Nasonex®) in seasonal allergic rhinitis: an active‐ and placebo‐controlled study

Allergy (Copenhagen), 1996-08, Vol.51 (8), p.569-576

1996

Volltextzugriff (PDF)

Effect of Mometasone Furoate on Early and Late Phase Inflammation in Patients with Seasonal Allergic Rhinitis

Annals of allergy, asthma, & immunology, 1998-11, Vol.81 (5), p.431-437

1998

Volltextzugriff (PDF)

Mometasone furoate: efficacy and safety in moderate asthma compared with beclomethasone dipropionate

Annals of allergy, asthma, & immunology, 2001-02, Vol.86 (2), p.203-210

2001

Volltextzugriff (PDF)

6BA Early efficacy signal demonstrated in advanced melanoma in a phase I trial of the oncogenic BRAF-selective inhibitor PLX4032

European journal of cancer supplements, 2009, Vol.7 (3), p.5-5

2009

Volltextzugriff (PDF)

Systemic bioavailability of inhaled corticosteroids: appropriate and comparable methodology

The European respiratory journal, 2001-07, Vol.18 (1), p.246-246

2001

Volltextzugriff (PDF)

Glucose utilization in vivo by human pulmonary neoplasms

Cancer, 1987-12, Vol.60 (11), p.2682-2689

1987

Volltextzugriff (PDF)

A Comparison of Double-Strength Beclomethasone Dipropionate (84 μg) MDI With Beclomethasone Dipropionate (42 μ) MDI in the Treatment of Asthma

Chest, 1997-07, Vol.112 (1), p.34-39

1997

Volltextzugriff (PDF)

Dose Ranging Study of Mometasone Furoate (Nasonex) in Seasonal Allergic Rhinitis

Annals of allergy, asthma, & immunology, 1997-07, Vol.79 (1), p.51-56

1997

Volltextzugriff (PDF)

Pattern and outcome of disease progression in phase I study of vemurafenib in patients with metastatic melanoma (MM)

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.8519-8519

2011

Volltextzugriff (PDF)

PLX4032 in metastatic colorectal cancer patients with mutant BRAF tumors

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.3534-3534

2010

Volltextzugriff (PDF)

Enhancement of tumor necrosis factor-induced endothelial cell injury by cycloheximide

American journal of physiology. Lung cellular and molecular physiology, 1990-08, Vol.259 (2), p.123-L129

1990

Volltextzugriff (PDF)

Early FDG-PET responses to PLX4032 in BRAF-mutant advanced melanoma

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.8529-8529

2010

Volltextzugriff (PDF)

PLX4032 (RG7204), a selective mutant RAF inhibitor: Clinical and histologic characteristics of therapy-associated cutaneous neoplasms in a phase I trial

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.8592-8592

2010

Volltextzugriff (PDF)

64 Once daily mometasone furoate aqueous nasal spray is as active as twice daily beclomethasone dipropionate for perennial allergic rhinitis

Journal of allergy and clinical immunology, 1996, Vol.97 (1), p.198-198

1996

Volltextzugriff (PDF)

1 – 25 von 82

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(74)
Mit Volltextzugriff
(66)

Publikationsform

Artikel
(81)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(43)
Humans
(42)
Life Sciences & Biomedicine
(41)
Male
(37)
Adult
(34)
Biological And Medical Sciences
(31)
Female
(29)
Medical Sciences
(27)
Middle Aged
(27)
Aged
(20)
Mometasone Furoate
(19)
Pharmacology. Drug Treatments
(17)
Adolescent
(16)
Anti-Inflammatory Agents - Administration & Dosage
(16)
Double-Blind Method
(16)
Pregnadienediols - Administration & Dosage
(16)
Allergy
(13)
Immunology
(13)
Histamine And Antagonists. Allergy
(12)
Animals
(11)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray

Comparison of once-daily to twice-daily treatment with mometasone furoate dry powder inhaler

Vemurafenlb Improves Overall Survival Compared to Dacarbazlne In Advanced BRAFV600E-mutated Melanoma: Updated Survival Results From a Phase III Randomised, Open-label, Multlcentre Trial

Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler

Comparison of the efficacy and safety of mometasone furoate dry powder inhaler to budesonide Turbuhaler

The Responsiveness of Disease-Specific and Generic Health Measures to Changes in the Severity of Asthma among Adults

Onset of action of mometasone furoate nasal spray (NASONEX®) in seasonal allergic rhinitis

Pharmacodynamic activity demonstrated in phase I for PLX3397, a selective inhibitor of FMS and Kit

Once-daily mometasone furoate dry powder inhaler in the treatment of patients with persistent asthma

Assessment by nasal biopsy of long-term use of mometasone furoate aqueous nasal spray (Nasonex) in the treatment of perennial rhinitis

A dose-ranging study of mometasone furoate aqueous nasal spray in children with seasonal allergic rhinitis

Once‐daily mometasone furoate aqueous nasal spray (Nasonex®) in seasonal allergic rhinitis: an active‐ and placebo‐controlled study

Effect of Mometasone Furoate on Early and Late Phase Inflammation in Patients with Seasonal Allergic Rhinitis

Mometasone furoate: efficacy and safety in moderate asthma compared with beclomethasone dipropionate

6BA Early efficacy signal demonstrated in advanced melanoma in a phase I trial of the oncogenic BRAF-selective inhibitor PLX4032

Systemic bioavailability of inhaled corticosteroids: appropriate and comparable methodology

Glucose utilization in vivo by human pulmonary neoplasms

A Comparison of Double-Strength Beclomethasone Dipropionate (84 μg) MDI With Beclomethasone Dipropionate (42 μ) MDI in the Treatment of Asthma

Dose Ranging Study of Mometasone Furoate (Nasonex) in Seasonal Allergic Rhinitis

Pattern and outcome of disease progression in phase I study of vemurafenib in patients with metastatic melanoma (MM)

PLX4032 in metastatic colorectal cancer patients with mutant BRAF tumors

Enhancement of tumor necrosis factor-induced endothelial cell injury by cycloheximide

Early FDG-PET responses to PLX4032 in BRAF-mutant advanced melanoma

PLX4032 (RG7204), a selective mutant RAF inhibitor: Clinical and histologic characteristics of therapy-associated cutaneous neoplasms in a phase I trial

64 Once daily mometasone furoate aqueous nasal spray is as active as twice daily beclomethasone dipropionate for perennial allergic rhinitis

Suchergebnisse filtern